CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-25 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +18,991 | $12.99 | $247K | 11,073,417 |
| 2022-02-24 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +186,467 | $13.03 | $2.4M | 11,054,426 |
| 2022-02-23 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +214,922 | $13.41 | $2.9M | 10,867,959 |
| 2022-02-22 | Yan Ming Chief Technology Officer | Sale | −20,000 | $13.44 | $269K | 8,089,792 |
| 2022-02-22 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +214,922 | $13.46 | $2.9M | 10,653,037 |
| 2022-02-18 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +166,229 | $14.12 | $2.3M | 10,438,115 |
| 2022-02-17 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +166,229 | $14.78 | $2.5M | 10,271,886 |
| 2022-02-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +166,200 | $14.98 | $2.5M | 10,105,657 |
| 2022-02-15 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +166,200 | $14.99 | $2.5M | 9,939,457 |
| 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +166,229 | $14.72 | $2.4M | 9,773,257 |
| 2022-02-10 | Yan Ming Chief Technology Officer | Sale | −14,706 | $15.01 | $221K | 8,115,086 |
| 2022-02-10 | Yan Ming Chief Technology Officer | Sale | −5,294 | $15.37 | $81K | 8,109,792 |
| 2022-02-07 | Jiang Wenbin President and CEO | Sale | −20,000 | $14.40 | $288K | 7,889,375 |
| 2021-12-31 | Imper Vera Director | Grant or award · Stock Option (Right to Buy) | +28,598 | 28,598 | ||
| 2021-12-04 | Jiang Wenbin President and CEO | Gift | −5,000 | 7,842,710 | ||
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +5,150,751 | 5,150,751 | ||
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +2,762,786 | $17.00 | $47.0M | 7,913,537 |
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +998,553 | 998,553 | ||
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +187,214 | $17.00 | $3.2M | 1,185,767 |
| 2021-07-27 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +507,724 | 507,724 |
Page 48 of 49 · 980 trades